Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis.
Cytokines
DNA methylation
Endotoxin tolerance
Monocytes
Sepsis
Journal
Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844
Informations de publication
Date de publication:
29 10 2019
29 10 2019
Historique:
received:
18
07
2019
accepted:
07
10
2019
entrez:
31
10
2019
pubmed:
31
10
2019
medline:
9
4
2020
Statut:
epublish
Résumé
Sepsis, a life-threatening organ dysfunction caused by a dysregulated systemic immune response to infection, associates with reduced responsiveness to subsequent infections. How such tolerance is acquired is not well understood but is known to involve epigenetic and transcriptional dysregulation. Bead arrays were used to compare global DNA methylation changes in patients with sepsis, non-infectious systemic inflammatory response syndrome, and healthy controls. Bioinformatic analyses were performed to dissect functional reprogramming and signaling pathways related to the acquisition of these specific DNA methylation alterations. Finally, in vitro experiments using human monocytes were performed to test the induction of similar DNA methylation reprogramming. Here, we focused on DNA methylation changes associated with sepsis, given their potential role in stabilizing altered phenotypes. Tolerized monocytes from patients with sepsis display changes in their DNA methylomes with respect to those from healthy controls, affecting critical monocyte-related genes. DNA methylation profiles correlate with IL-10 and IL-6 levels, significantly increased in monocytes in sepsis, as well as with the Sequential Organ Failure Assessment score; the observed changes associate with TFs and pathways downstream to toll-like receptors and inflammatory cytokines. In fact, in vitro stimulation of toll-like receptors in monocytes results in similar gains and losses of methylation together with the acquisition of tolerance. We have identified a DNA methylation signature associated with sepsis that is downstream to the response of monocytes to inflammatory signals associated with the acquisition of a tolerized phenotype and organic dysfunction.
Sections du résumé
BACKGROUND
Sepsis, a life-threatening organ dysfunction caused by a dysregulated systemic immune response to infection, associates with reduced responsiveness to subsequent infections. How such tolerance is acquired is not well understood but is known to involve epigenetic and transcriptional dysregulation.
METHODS
Bead arrays were used to compare global DNA methylation changes in patients with sepsis, non-infectious systemic inflammatory response syndrome, and healthy controls. Bioinformatic analyses were performed to dissect functional reprogramming and signaling pathways related to the acquisition of these specific DNA methylation alterations. Finally, in vitro experiments using human monocytes were performed to test the induction of similar DNA methylation reprogramming.
RESULTS
Here, we focused on DNA methylation changes associated with sepsis, given their potential role in stabilizing altered phenotypes. Tolerized monocytes from patients with sepsis display changes in their DNA methylomes with respect to those from healthy controls, affecting critical monocyte-related genes. DNA methylation profiles correlate with IL-10 and IL-6 levels, significantly increased in monocytes in sepsis, as well as with the Sequential Organ Failure Assessment score; the observed changes associate with TFs and pathways downstream to toll-like receptors and inflammatory cytokines. In fact, in vitro stimulation of toll-like receptors in monocytes results in similar gains and losses of methylation together with the acquisition of tolerance.
CONCLUSION
We have identified a DNA methylation signature associated with sepsis that is downstream to the response of monocytes to inflammatory signals associated with the acquisition of a tolerized phenotype and organic dysfunction.
Identifiants
pubmed: 31665078
doi: 10.1186/s13073-019-0674-2
pii: 10.1186/s13073-019-0674-2
pmc: PMC6820973
doi:
Substances chimiques
Cytokines
0
Inflammation Mediators
0
DNA
9007-49-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
66Références
Nature. 2007 Jun 21;447(7147):972-8
pubmed: 17538624
Front Immunol. 2017 Feb 01;8:50
pubmed: 28203237
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14978-83
pubmed: 19706447
Nat Commun. 2016 Jan 29;7:10478
pubmed: 26823093
J Clin Invest. 1991 Nov;88(5):1747-54
pubmed: 1939659
Nucleic Acids Res. 2017 Sep 29;45(17):10002-10017
pubmed: 28973458
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Cell Mol Life Sci. 2017 Nov;74(22):4133-4157
pubmed: 28631008
J Biol Chem. 2007 Sep 14;282(37):26857-64
pubmed: 17646159
Cell. 2016 Nov 17;167(5):1354-1368.e14
pubmed: 27863248
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
Crit Care Med. 2001 Jan;29(1):129-33
pubmed: 11176172
Genome Biol. 2016 Jan 13;17:4
pubmed: 26758199
Nat Rev Immunol. 2017 Jul;17(7):407-420
pubmed: 28436424
Nature. 2015 Sep 17;525(7569):389-393
pubmed: 26287468
PLoS Genet. 2009 Nov;5(11):e1000745
pubmed: 19956686
MBio. 2010 Oct 26;1(5):null
pubmed: 20978539
Am J Physiol Lung Cell Mol Physiol. 2005 Sep;289(3):L429-37
pubmed: 16093364
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
Nat Rev Immunol. 2015 Jan;15(1):7-17
pubmed: 25534619
J Immunol. 2011 Jun 15;186(12):7243-54
pubmed: 21576504
J Immunol. 2005 Jul 1;175(1):461-8
pubmed: 15972680
Crit Care. 2006;10(5):233
pubmed: 17044947
Semin Cell Dev Biol. 2017 Sep;69:158-171
pubmed: 28774578
J Infect Dis. 2018 Jan 17;217(3):393-404
pubmed: 28973671
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nat Methods. 2012 Feb 28;9(3):215-6
pubmed: 22373907
Genome Biol. 2013;14(9):R99
pubmed: 24028770
Trends Immunol. 2009 Oct;30(10):475-87
pubmed: 19781994
Nat Immunol. 2016 Apr;17(4):406-13
pubmed: 26950237
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
J Immunol. 1999 Aug 15;163(4):2041-8
pubmed: 10438942
Cell. 2018 Jan 11;172(1-2):147-161.e12
pubmed: 29328910
Inflammation. 2015 Aug;38(4):1599-608
pubmed: 25676437
Immunity. 2015 Mar 17;42(3):484-98
pubmed: 25746953
Int J Artif Organs. 2018 May;41(5):247-253
pubmed: 29562813
JAMA. 1997 Apr 2;277(13):1058-63
pubmed: 9091694
Genome Res. 2012 Sep;22(9):1680-8
pubmed: 22955980
Nat Rev Immunol. 2005 Dec;5(12):953-64
pubmed: 16322748
J Biol Chem. 2008 Nov 21;283(47):32198-208
pubmed: 18809684
Nature. 2018 Feb 1;554(7690):123-127
pubmed: 29364877
Nat Med. 1997 Jun;3(6):678-81
pubmed: 9176497